Treating chronic hepatitis C (Hepatitis C Infection)

Treating chronic hepatitis C
Treating chronic hepatitis C 10 years of progress 0 20 40 60 80 100 % Sustained vriologic response 1991 2001 PEG-Intron/Rebetol Previous slide Next slide Back to first slide View graphic version

Viral Hepatitis
Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;129:797 800

GSKVaccines Chronic Liver Disease
Alcoholic cirrhosis Chronic hepatitis C Autoimmune hepatitis Primary biliary cirrhosis TWINRIX is generally well tolerated. In clinical trials, the most common solicited adverse events were soreness and

#1 Hepatitis C Primer - Information about the Hepatitis C Virus
severity of chronic hepatitis C is controversial. There is no question that HCV can lead to cirrhosis and hepatocellur carcinoma (HCC) and that end-stage chronic hepatitis C is now the leading